Abstract:Early studies suggested macrophages might play roles in inflammation-associated benign prostatic hyperplasia (BPH) development, yet the underlying mechanisms remain unclear. Here we first showed that CD68(+) macrophages were identified in both epithelium and the stromal area of human BPH tissues. We then established an in vitro co-culture model with prostate epithelial and macrophage cell lines to study the potential impacts of infiltrating macrophages in the BPH development and found that co-culturing prostate epithelial cells with macrophages promoted migration of macrophages. In a three-dimensional culture system, the sphere diameter of BPH-1 prostate cells was significantly increased during coculture with THP-1 macrophage cells. Mechanism dissection suggested that expression levels of epithelial-mesenchymal transition (EMT) markers, such as N-cadherin, Snail, and TGF-beta 2, were increased, and administration of anti-TGF-beta 2 neutralizing antibody during co-culture suppressed the EMT and THP-1-mediated growth of BPH-1 cells, suggesting THP-1 might go through EMT to influence the BPH development and progression. Importantly, we found that modulation of androgen receptor (AR) in BPH-1 and mPrE cells significantly increased THP-1 and RAW264.7 cell migration, respectively, and enhanced expression levels of EMT markers, suggesting that AR in prostate epithelial cells might play a role in promoting macrophage-mediated EMT in prostate epithelial cells. Silencing AR function via an AR degradation enhancer, ASC-J9, decreased the macrophage migration to BPH-1 cells and suppressed EMT marker expression. Together, these results provide the first evidence to demonstrate that prostate epithelial AR function is important for macrophage-mediated EMT and proliferation of prostate epithelial cells, which represents a previously unrecognized role of AR in the cross-talk between macrophages and prostate epithelial cells. These results may provide new insights for a new therapeutic approach to battle BPH via targeting AR and AR-mediated inflammatory signaling pathways. (Molecular Endocrinology 26: 1707-1715, 2012)

Trihydrophobin 1 attenuates androgen signal transduction through promoting androgen receptor degradation.

Correction: Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer.

PC-1 Works in Conjunction with E3 Ligase CHIP to Regulate Androgen Receptor Stability and Activity

Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cells.

Androgen regulated HN1 leads proteosomal degradation of androgen receptor (AR) and negatively influences AR mediated transactivation in prostate cells

Smad3 Represses Androgen Receptor-Mediated Transcription

Cyclin D3/CDK11(p58) Complex is Involved in the Repression of Androgen Receptor

Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo

Androgen receptor deficiency-induced TUG1 in suppressing ferroptosis to promote benign prostatic hyperplasia through the miR-188-3p/GPX4 signal pathway

Differential Regulation of Androgen Receptor by Pim-1 Kinases Via Phosphorylation-Dependent Recruitment of Distinct Ubiquitin E3 Ligases

Combined treatment with dihydrotestosterone and lipopolysaccharide modulates prostate homeostasis by upregulating TNF-α from M1 macrophages and promotes proliferation of prostate stromal cells

Integrative Analysis of AR-mediated Transcriptional Regulatory Network Reveals IRF1 As an Inhibitor of Prostate Cancer Progression.

Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.

Trihydrophobin 1 Is A New Negative Regulator Of A-Raf Kinase

Cell Adhesion Regulates Expression of the Androgen Receptor and Coregulators in Different Prostate Cancer Cells

Negative Role of Trihydrophobin 1 in Breast Cancer Growth and Migration

Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening

Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer

Inhibiting CBP Decreases AR Expression and Inhibits Proliferation in Benign Prostate Epithelial Cells

ASB1 inhibits prostate cancer progression by destabilizing CHCHD3 via K48-linked ubiquitination

Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor